Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record.

Citalopram in pregnancy and lactation

Heikkinen, Tuija, Ekblad, Ulla, Kero, Pentti, Ekblad, Satu, Laine, Kari·2002·Clinical Pharmacology & Therapeutics

Abstract

Background: Although citalopram has gained wide acceptance in the treatment of depression and anxiety disorders, its use during pregnancy and lactation has been poorly characterized. The aim of this study was to examine the efficacy and safety of citalopram in relation to concentrations of citalopram and its metabolites during pregnancy and lactation. Methods: Eleven mothers taking citalopram and their infants were enrolled in the study, and a control group of 10 women who were not taking medication were prospectively matched for confounding obstetric characteristics at the time of delivery. Plasma and breast milk samples were collected from mother/infant pairs during pregnancy, at delivery, and for up to 2 months after delivery. Trough plasma and breast milk concentrations of citalopram, desmethylcitalopram, and didesmethylcitalopram were measured by HPLC. The pregnancy outcome was recorded, and the neurodevelopment of children was monitored for up to 1year. Results: Although the citalopram dose of 20 mg to 40 mg once daily resulted in low maternal trough plasma concentrations (range, 46‐214 nmol/L) and metabolites during pregnancy, only one subject required an increase of daily dose. The mean didesmethylcitalopram‐desmethylcitalopram metabolic ratio was significantly higher during pregnancy (54%, P < .001) than at 2 months after delivery, indicating induction of cytochromeP450 (CYP) 2D6 during pregnancy. At delivery, the trough plasma citalopram, desmethylcitalopram, and didesmethylcitalopram concentrations in the infants were 64%, 66%, and 68% ofthe maternal concentrations, respectively. The citalopram and metabolite concentrations in the milk were 2‐ to 3‐fold higher compared with maternal plasma concentrations, but theinfant citalopram and metabolite plasma concentrations were very low or undetectable. Thedelivery outcome and the neurodevelopment of all infants up to the age of 1 year were normal. Conclusion: Even though the sample size was limited, results from this prospective clinical trial suggest uncomplicated pregnancy outcome in mothers using citalopram during pregnancy and minimal exposure of the infants to citalopram during lactation. However, maternal therapeutic drug monitoring of citalopram should be recommended to minimize fetal exposure. Clinical Pharmacology & Therapeutics (2002) 72, 184–191; doi: 10.1067/mcp.2002.126181

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1067/mcp.2002.126181

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 181

Metadata

Authors
Heikkinen, T., Ekblad, U., Kero, P., Ekblad, S., & Laine, K.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2002-08
Volume
72
Issue
2
Pages
184-191
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2038195864
Cited by
181
References
0
FWCI
13.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Citalopram in pregnancy and lactation. https://app.cochat.ai/papers/10.1067/mcp.2002.126181
The paper
Heikkinen, T., Ekblad, U., Kero, P., Ekblad, S., & Laine, K. (2002). Citalopram in pregnancy and lactation. Clinical Pharmacology & Therapeutics. https://doi.org/10.1067/mcp.2002.126181

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.